Andreas Teufel

机构：Heidelberg University, Universität Greifswald, Medizinische Fakultät Mannheim · ORCID：0000-0001-7953-8927

发表论文 457 篇 · 总被引 16003 次 · h-index 61

代表论文

• Digestive cancers: mechanisms, therapeutics and management (2025 · Signal Transduction and Targeted Therapy · 被引 75)
• Evaluation of four chatbots in autoimmune liver disease: A comparative analysis (2024 · Annals of Hepatology · 被引 16)
• Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) (2025 · BMJ Open · 被引 12)
• Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort (2024 · Zeitschrift für Gastroenterologie · 被引 12)
• Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges (2024 · Engineering · 被引 12)
• Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab (2024 · JHEP Reports · 被引 11)